Biocon Biologics
Arunprasath D is currently serving as a Senior Scientist at Biocon Biologics, where responsibilities include Molecular Biology and Cell Line Development at the Biocon Research Centre since July 2022. Prior to this role, Arunprasath D gained experience as an SRFP summer fellow at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) in September to November 2019, focusing on the study of the Drosophila haematopoietic system through in vitro transcription and in situ hybridization. Arunprasath D holds an M.S. in Pharm Biotechnology from the National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, Mohali, completed in 2022, and a Bachelor of Pharmacy (BPharm) from PSG College of Pharmacy, graduated in 2020.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics